Trader denies firm’s link to Pharmally
A BUSINESSWOMAN clarified that Pharmally Biological and Pharmaceutical Company is not a sister company of the controversial Pharmally Pharmaceutical Corp.
Appearing before the House Quad Committee, Businesswoman-turned-politician Rose Nono Lin, denied the link of her company to that of Pharmally Pharmaceutical, that is being investigated in the House of Representatives.
The owner of the now defunct Pharmally Biological, clarified that she is neither an official nor a shareholder of the said controversial pharmaceutical company.
She reiterated that the Pharmally Biological is separate and different from Pharmally Pharmaceutical.
Nono-Lin also issued a similar clarification before the Senate Blue Ribbon Committee in 2021 when it investigated the P8 billion contract bagged by Pharmally Pharmaceutical for the provision of medical supplies to the Duterte government’s Covid-19 response efforts even as the firm had only P625,000 in paid-up capital.
“I have no involvement in the operations of Pharmally Pharmaceutical Corp. Pharmally Biological is a different entity, and has no shares or stocks with Pharmally Pharmaceutical,” Nono-Lin pointed out.
“I am just an ordinary citizen and businesswoman making a living in a legal and fair means. All the accusations against me and my family were purely hearsay,” she added.
In several Congressional hearings, there are documents being shown that Nono-Lin’s husband, Lin Wei Xiong, a Hong Kong national, is the financial manager of Pharmally Pharmaceutical and a close associate of former presidential adviser Michael Yang, who provided the financing to said company.
However, the camp of Nono-Lin pointed out though that said documents did not prove that Pharmally Biological and Pharmally Pharmaceutical were sister companies, or that Lin was an official or shareholder of the latter or has a contract with the government.
While it was acknowledged that Lin’s husband and Yang were partners in some activities, she pointed out that it did not prove anything.
AUTHOR PROFILE
Nation
